Why the study?
Do angiotensin II receptor blockers (ARBs) provide an effective alternative to ACE inhibitors in the management of chronic heart failure?
Population
Patients with chronic heart failure, particularly those who are ACE inhibitor-intolerant
Comparison
Angiotensin II receptor blockers (ARBs) vs Angiotensin-converting enzyme (ACE) inhibitors
Design
Review
Authors
Loading...
Supports restricting ARBs to ACEI-intolerant HF patients; leaves open need for direct randomized comparisons.
Do angiotensin II receptor blockers (ARBs) provide an effective alternative to ACE inhibitors in the management of chronic heart failure?
ARBs are currently recommended primarily as an alternative therapy for chronic heart failure patients who are intolerant to ACE inhibitors.
Jamali et al. (2001) studied this question.